89 related articles for article (PubMed ID: 29923428)
1. Economic burden associated with adverse events of special interest in patients with relapsed Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in the United States.
Zhang X; Song X; Lopez-Gonzalez L; Jariwala-Parikh K; Cong Z
Expert Rev Pharmacoecon Outcomes Res; 2018 Oct; 18(5):573-580. PubMed ID: 29923428
[TBL] [Abstract][Full Text] [Related]
2. Burden of hospitalization in relapsed acute lymphoblastic leukemia.
Barlev A; Lin VW; Song X
Curr Med Res Opin; 2016 Jul; 32(7):1209-12. PubMed ID: 26960412
[TBL] [Abstract][Full Text] [Related]
3. Healthcare burden and reimbursement of hospitalization during chemotherapy for adults with Ph-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia in France: a retrospective chart review.
Dombret H; Thomas X; Chevallier P; Nivot E; Reitan J; Barber B; Barlev A; Mohty M
J Med Econ; 2016 Nov; 19(11):1034-1039. PubMed ID: 27207188
[TBL] [Abstract][Full Text] [Related]
4. Economic Burden of Veno-occlusive Disease in Patients With B-cell Acute Lymphoblastic Leukemia in the United States.
Zhang X; Song X; Lopez-Gonzalez L; Jariwala-Parikh K; Romanov V; Cong Z
Clin Ther; 2018 Oct; 40(10):1711-1719.e1. PubMed ID: 30196935
[TBL] [Abstract][Full Text] [Related]
5. Health Care Resource Utilization and Total Costs of Care for Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis.
Ito D; Feng C; Fu C; Kim C; Wu J; Dalton D; Epstein J; Snider JT; DuVall AS
Clin Ther; 2024 Jan; 46(1):3-11. PubMed ID: 37981560
[TBL] [Abstract][Full Text] [Related]
6. Retrospective chart review of hospitalizations and costs associated with the treatment of adults with Philadelphia-negative B-cell relapsed or refractory acute lymphoblastic leukemia in Belgium.
Maertens J; Graux C; Breems D; Havelange V; Wittnebel S; Strens D; Hoefkens C
Acta Clin Belg; 2017 Dec; 72(6):429-433. PubMed ID: 28406385
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective.
Delea TE; Amdahl J; Boyko D; Hagiwara M; Zimmerman ZF; Franklin JL; Cong Z; Hechmati G; Stein A
J Med Econ; 2017 Sep; 20(9):911-922. PubMed ID: 28631497
[TBL] [Abstract][Full Text] [Related]
8. Estimation of Total Costs in Pediatric and Young Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Receiving Tisagenlecleucel from a U.S. Hospital's Perspective.
Yang H; Hao Y; Qi CZ; Chai X; Wu EQ
J Manag Care Spec Pharm; 2020 Aug; 26(8):971-980. PubMed ID: 32525730
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
10. Societal burden of cluster headache in the United States: a descriptive economic analysis.
Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
[TBL] [Abstract][Full Text] [Related]
11. Burden of chemotherapy in patients with relapsed/refractory acute myeloid leukemia in the United States: a retrospective claims database study.
Pandya BJ; Chen CC; McGuiness CB; Sullivan L; Feng Q; Walsh E; Borate U
Expert Rev Hematol; 2022 Sep; 15(9):857-866. PubMed ID: 35924860
[TBL] [Abstract][Full Text] [Related]
12. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
13. Annual Burden and Costs of Hospitalization for High-Need, High-Cost Patients With Chronic Gastrointestinal and Liver Diseases.
Nguyen NH; Khera R; Ohno-Machado L; Sandborn WJ; Singh S
Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1284-1292.e30. PubMed ID: 29474966
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of rituximab in addition to standard of care chemotherapy for adult patients with acute lymphoblastic leukemia.
Nam J; Milenkovski R; Yunger S; Geirnaert M; Paulson K; Seftel M
J Med Econ; 2018 Jan; 21(1):47-59. PubMed ID: 28837377
[TBL] [Abstract][Full Text] [Related]
15. Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain.
Kwong WJ; Diels J; Kavanagh S
Ann Pharmacother; 2010 Apr; 44(4):630-40. PubMed ID: 20197473
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.
Liu L; Jiao W; Zhang Y; Qu Q; Li X; Wu D
Leuk Res; 2015 Mar; 39(3):323-8. PubMed ID: 25638269
[TBL] [Abstract][Full Text] [Related]
17. Expenditures among young adults with acute lymphoblastic leukemia by site of care.
Wolfson JA; Bhatia S; Ginsberg J; Becker LK; Bernstein D; Henk HJ; Lyman GH; Nathan PC; Puccetti D; Wilkes JJ; Winestone LE; Kenzik KM
Cancer; 2021 Jun; 127(11):1901-1911. PubMed ID: 33465248
[TBL] [Abstract][Full Text] [Related]
18. Hospitalization rate and costs in acute lymphoblastic leukemia of childhood in a low-income group: Financial impact in Northeast Mexico.
Jaime-Pérez JC; Fernández LT; Jiménez-Castillo RA; Colunga-Pedraza JE; Padilla-Medina JR; Mancías-Guerra C; Gómez-Almaguer D
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598592
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.
Burudpakdee C; Lin HM; Wang W; Seetasith A; Zhu Y; Bonthapally V; Carson KR
J Med Econ; 2016 Oct; 19(10):965-72. PubMed ID: 27152635
[TBL] [Abstract][Full Text] [Related]
20. Costs of relapsed diffuse large B-cell lymphoma among Medicare patients.
Huntington S; Keshishian A; McGuire M; Xie L; Baser O
Leuk Lymphoma; 2018 Dec; 59(12):2880-2887. PubMed ID: 29936866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
